Neuropace, Inc.

The momentum for this stock is not very good. Neuropace, Inc. has good growth characteristics. Neuropace, Inc. is not very popular among insiders. Neuropace, Inc. is a mediocre stock to choose.

News

NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Ticker Report Shares of NeuroPace, Inc. (NASDAQ:NPCE - Get Free Report) have received an average recommendation of "Moderate Buy" from the seven brokerages that are presently covering the firm, Marketbeat Ratings...\n more…

NeuroPace, Inc. (NASDAQ:NPCE) Given Average Recommendation of "Moderate Buy" by Analysts

Zolmax Shares of NeuroPace, Inc. (NASDAQ:NPCE - Get Free Report) have earned an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the firm, MarketBeat.com reports...\n more…

NeuroPace Strengthens Management Team with Two Key Appointments

Globe Newswire Appointed former key developer of RNS System as new Vice President of Research and Development Appointed former head of commercial marketing for Boston Scientific's DBS franchise as the new Vice...\n more…

NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences

Globe Newswire MOUNTAIN VIEW, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced...\n more…

NeuroPace to Participate in Upcoming Healthcare Conferences in September

Globe Newswire MOUNTAIN VIEW, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced...\n more…

NeuroPace: Only For Those With Strong Nerves

SeekingAlpha NeuroPace: Only For Those With Strong Nerves...\n more…